These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 12156379

  • 21. Problems of HIV infection for women in Africa.
    Goethel W.
    IPPF Med Bull; 1988 Jun; 22(3):1-3. PubMed ID: 12342059
    [Abstract] [Full Text] [Related]

  • 22. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A, Grunewald C, Saltvedt S, Valentin L, Almström H.
    Acta Obstet Gynecol Scand; 2006 Jun; 85(5):534-8. PubMed ID: 16752230
    [Abstract] [Full Text] [Related]

  • 23. [Economic analysis of the dissemination of a medical innovation: prenatal diagnosis by early amniocentesis as an example. Part 2. Facilitating decision making in public health for optimal dissemination of an innovation].
    Gardent H, Fardeau M, Lanöe JL, Kerleau M.
    Rev Epidemiol Sante Publique; 1984 Jun; 32(2):97-106. PubMed ID: 6237394
    [Abstract] [Full Text] [Related]

  • 24. [Prenatal diagnosis of the carrier of the translocation form of Down's disease].
    Macek M, Chrz R, Bresták M, Cervenka J, Kotásek A.
    Cesk Gynekol; 1972 Jun; 37(6):433-5. PubMed ID: 4262183
    [No Abstract] [Full Text] [Related]

  • 25. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women.
    Hwa HL, Yen MF, Lin CL, Ko TM, Hsieh FJ, Chen TH.
    J Eval Clin Pract; 2008 Apr; 14(2):191-7. PubMed ID: 18284525
    [Abstract] [Full Text] [Related]

  • 26. Understandings of Down's syndrome: a Q methodological investigation.
    Bryant LD, Green JM, Hewison J.
    Soc Sci Med; 2006 Sep; 63(5):1188-200. PubMed ID: 16644080
    [Abstract] [Full Text] [Related]

  • 27. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK, Wald NJ.
    J Med Screen; 2007 Sep; 14(1):5-7. PubMed ID: 17362564
    [Abstract] [Full Text] [Related]

  • 28. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K, Sandall J.
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [Abstract] [Full Text] [Related]

  • 29. Prenatal diagnosis in New South Wales: comparative view of the first 1000 cases of chromosomal, sex-linked, and metabolic referrals.
    Daniel A, Lam-Po-Tang PR.
    Med J Aust; 1978 Oct 07; 2(8):352-7. PubMed ID: 153444
    [Abstract] [Full Text] [Related]

  • 30. Fetal hyperechogenic bowel and Down's syndrome.
    Nyberg DA, Resta RG, Mahony BS, Dubinsky T, Luthy DA, Hickok DE, Luthardt FW.
    Ultrasound Obstet Gynecol; 1993 Sep 01; 3(5):330-3. PubMed ID: 12797255
    [Abstract] [Full Text] [Related]

  • 31. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases.
    Schmidt P, Staboulidou I, Soergel P, Wüstemann M, Hillemanns P, Scharf A.
    Arch Gynecol Obstet; 2007 Jun 01; 275(6):469-74. PubMed ID: 17333228
    [Abstract] [Full Text] [Related]

  • 32. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S, Phadke SR.
    J Perinatol; 2007 Sep 01; 27(9):550-5. PubMed ID: 17611609
    [Abstract] [Full Text] [Related]

  • 33. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan 01; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

  • 34. High incidence of Down's syndrome in infants of diabetic mothers.
    Narchi H, Kulaylat N.
    Arch Dis Child; 1997 Sep 01; 77(3):242-4. PubMed ID: 9370905
    [Abstract] [Full Text] [Related]

  • 35. The present role of genetic counseling.
    Gilgenkrantz S.
    Sem Hop Paris; 1977 Feb 23; 53(8):503-5. PubMed ID: 12259967
    [Abstract] [Full Text] [Related]

  • 36. Congenital cardiac disease in children with Down's syndrome in Guatemala.
    Vida VL, Barnoya J, Larrazabal LA, Gaitan G, de Maria Garcia F, Castañeda AR.
    Cardiol Young; 2005 Jun 23; 15(3):286-90. PubMed ID: 15865831
    [Abstract] [Full Text] [Related]

  • 37. [Clinical diagnosis of Down's syndrome based on 11 signs. Epidemiological analysis of the specificity of the studied signs].
    Martínez-Frías ML, Bermejo Sánchez E, Rodríguez Pinilla E.
    An Esp Pediatr; 1996 Nov 23; 45(5):522-6. PubMed ID: 9036786
    [Abstract] [Full Text] [Related]

  • 38. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 23; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 39. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM, Collins VR, Haynes K, Sheffield LJ, Francis I, Forbes R, Halliday JL.
    J Med Screen; 2006 Apr 23; 13(1):8-13. PubMed ID: 16569299
    [Abstract] [Full Text] [Related]

  • 40. [Karyological characteristics of Down's syndrome: clinical and theoretical aspects].
    Kovaleva NV, Butomo IV, Verlinskaia DK, Il'iashenko TN, Pantova IG, Prozorova MV, Khitrikova LE, Shandlorenko SK.
    Tsitologiia; 1999 Apr 23; 41(12):1014-21. PubMed ID: 10658271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.